Cargando…

296. Description of Super-infections in Hospitalized Patients with COVID-19

BACKGROUND: The rate of bacterial and fungal super-infections (SI) in inpatients with COVID-19 is unknown. In this study, we aimed to identify and describe patients that developed secondary infections while hospitalized with COVID-19. METHODS: We performed a retrospective chart review on patients ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kludjian, Geena, Spivack, Stephanie, Gallucci, Stefania, Kilpatrick, Laurie, Mishkin, Aaron D, Sajjan, Umadevi, Tam, Vincent, Gallagher, Jason C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643719/ http://dx.doi.org/10.1093/ofid/ofab466.498

Ejemplares similares

277. Low Rates of Bacterial Co-infection in Hospitalized Patients with COVID-19
por: Spivack, Stephanie, et al.
Publicado: (2021)

131. A Pharmacist Led Antimicrobial Stewardship Pilot at Discharge Improves Outpatient Antibiotic Utilization
por: Hiryak, Kayla, et al.
Publicado: (2021)

Improving antibiotic utilization through an outpatient stewardship initiative
por: Hiryak, Kayla M., et al.
Publicado: (2023)

1040. Real-World Implementation of Dolutegravir-Lamivudine to Achieve and Maintain HIV-1 Viral Suppression at an Academic Medical Center
por: Hiryak, Kayla, et al.
Publicado: (2020)

647. Cefepime Versus Carbapenems for the Treatment of ESBL-producing Enterobacterales among Non-blood Isolates
por: Garcia, Brandon, et al.
Publicado: (2022)

296. IV-to-PO Antibiotic Step-down Therapy for Treatment of Uncomplicated Streptococcal Bloodstream Infections
por: Ramos-Otero, Gerardo P, et al.
Publicado: (2020)

309. The Impact of Addiction Medicine Consultation on Discharges Against Medical Advice in Patients with Opioid Use Disorder and Staphylococcus Aureus Bacteremia
por: Spivack, Stephanie, et al.
Publicado: (2020)

1264. Assessment of In Vivo Efficacy of CF-296 in addition to Vancomycin (VAN) and Daptomycin (DAP) against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model
por: Asempa, Tomefa E, et al.
Publicado: (2020)

113. Impact of Urinalysis with Reflex to Culture on Antimicrobial Prescribing Patterns for Patients with a Positive Urine Culture
por: Diehl, Nicolette, et al.
Publicado: (2020)

1703. Hematologic Toxicity of Valganciclovir Prophylaxis in Solid Organ Transplant Recipients as a Function of Weight-adjusted Ganciclovir Exposure
por: Campanella, Toni A, et al.
Publicado: (2020)

P296: Epidemiological profile and management of accidental blood exposure, Bamako
por: Traoré, A, et al.
Publicado: (2013)

Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support
por: Miller, Michelle, et al.
Publicado: (2022)

PM296. SORCS2 regulates alcohol withdrawal severity and excitatory synaptic transmission
por: Smith, Andrew H., et al.
Publicado: (2016)

296. The Hepatitis C Cascade of Care across Four Safety Net Settings in the Southeast
por: Schranz, Asher J, et al.
Publicado: (2019)

296. Molecular epidemiology and clinical features of pneumococcal pneumonia at a university hospital in Japan
por: Nakao, Takumi, et al.
Publicado: (2023)

232. Safety and Effectiveness of Intravenous to Oral De-escalation Compared to Continued Vancomycin Therapy in Orthopedic Infections
por: Gallagher, Chanah, et al.
Publicado: (2021)

470. Relapsing COVID-19 Pneumonia in Patients Receiving Rituximab Therapy
por: Gallagher, Jolie, et al.
Publicado: (2021)

296 A Bayesian Approach to Predicting Outcomes During the Initial COVID-19 Outbreak
por: Nelson, J., et al.
Publicado: (2021)

296. Outcomes From a Novel Transition-of-Care OPAT Service Targeting Orthopedic Device-Related Infections
por: Hassan, Sidra, et al.
Publicado: (2018)

Contents of volume 296 (2005)
Publicado: (2005)

Health Tract, No. 296: Hemorrhage
Publicado: (1867)

2836. Prostate Abscess due to Staphylococcus aureus: a Retrospective Case Series
por: Pellis, Zachary, et al.
Publicado: (2023)

2435. Clinical Outcomes With Ceftolozane–Tazobactam in Patients With Multidrug-Resistant (MDR) Pseudomonas aeruginosa Bloodstream Infections: A Multi-Center Study
por: King, Madeline, et al.
Publicado: (2018)

2073. Positive Clinical Impact of MALDI-TOF for the Management of Inpatient Pneumonia Without Additional Antimicrobial Stewardship (AS) Support
por: Porreca, Ann Marie, et al.
Publicado: (2018)

2382. Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study
por: Elabor, Abdulrahman, et al.
Publicado: (2018)

Secretory Cells: New Players in Small Airway Mucosal Immunity?
por: Sajjan, Umadevi
Publicado: (2022)

Using more than 801 296 small-molecule crystal structures to aid in protein structure refinement and analysis
por: Cole, Jason C., et al.
Publicado: (2017)

158. Intra- and Inter-hospital Epidemiology of Carbapenem-resistant klebsiella Pneumoniae in US Hospitals
por: Luterbach, Courtney, et al.
Publicado: (2020)

296. SARS-CoV-2 Illness Severity and Early Hospitalization Outcomes in a Multicenter Prospective Cohort Study Among Veterans
por: Ross, Jennifer M, et al.
Publicado: (2022)

Ceftolozane-tazobactam for the Treatment of Multi Drug-resistant Pseudomonas aeruginosa (MDRPA) Infections
por: Molnar, Esther, et al.
Publicado: (2017)

Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19
por: Rekhtman, Sergey, et al.
Publicado: (2021)

2011. Reaction of Clinicians to Positive Respiratory Viral Panels in Non-critically Ill Patients Without Bacterial Infection
por: Gallagher, Jason C, et al.
Publicado: (2019)

Using more than 801 296 small-molecule crystal structures to aid in protein structure refinement and analysis. Addendum
por: Cole, Jason C., et al.
Publicado: (2017)

2407. Multidisciplinary Endocarditis Team (MET): Establishing a Baseline of Infective Endocarditis in People Who Use Injection Drugs (PWID)
por: Patel, Kaya, et al.
Publicado: (2023)

188. Plan PDD (patient directed discharge): Oral contingency plans for people who inject drugs (PWID) with Staphylococcus aureus bacteremia (SAB) who leave the hospital prematurely
por: Duffield, Olivia, et al.
Publicado: (2023)

2247. Improvements in Antibiotic Stewardship for Patients Who Use Injection Drugs: Subgroup Analysis of Patients with Bacteremia
por: Duffield, Olivia, et al.
Publicado: (2023)

225. Dalbavancin Usage in Patients Who Inject Drugs (PWID)
por: Patel, Kaya, et al.
Publicado: (2023)

104. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Bettger, Caitlin C, et al.
Publicado: (2020)

2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients with Multidrug-Resistant (MDR) Pseudomonas aeruginosa (PA) Infections
por: Hart, Delaney E, et al.
Publicado: (2019)

Keyword index to volumes 296–307 (2005)
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_dcpjcr7ien70j18bcflvmkkomn